SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-089705
Filing Date
2024-04-08
Accepted
2024-04-08 17:01:06
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d823567ds3.htm S-3 165933
2 EX-5.1 d823567dex51.htm EX-5.1 8797
3 EX-23.2 d823567dex232.htm EX-23.2 2039
4 EX-23.3 d823567dex233.htm EX-23.3 2071
5 EX-FILING FEES d823567dexfilingfees.htm EX-FILING FEES 14807
6 GRAPHIC g823567g0406000029989.jpg GRAPHIC 2476
7 GRAPHIC g823567g40j26.jpg GRAPHIC 60432
  Complete submission text file 0001193125-24-089705.txt   281679
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278559 | Film No.: 24830278
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)